GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?Zacks Investment Research • Thursday
GSK plc (GSK) Presents at 2026 European Society for Medical Oncology (ESMO) Annual Congress TranscriptSeeking Alpha • Tuesday
Can Specialty Meds Offset GSK's $2.2B Legal Charges and Sizzling R&D Setbacks on Oct. 28?24/7 Wall Street • 10/24/26
Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/21/26
GSK hepatitis B drug approval supports £2.2bn sales forecast, Jefferies saysProactive Investors • 10/21/26
Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)Business Wire • 10/20/26
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatmentReuters • 10/20/26
Jefferies backs GSK with 2,500p target after positive lung cancer drug resultsProactive Investors • 10/19/26
GSK: Maintaining Strong Buy For LAI HIV Sales Growth And Further Oncology ExpansionSeeking Alpha • 10/14/26